Amylin: A Multi‐Functional Pancreatic Hormone—A Review
Diabetes, Obesity and Metabolism · Published 2026-08-05 · DOI 10.1111/dom.71146
Free full text
Authors (2)
Christelle Le Foll, Thomas A. Lutz
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Foll, C., Lutz, T. (2026). Amylin: A Multi‐Functional Pancreatic Hormone—A Review. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71146
Related articles
- A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance · Nature Metabolism · 2026 · Cites or is cited by this article
- Economic Impact of Multidisciplinary Pre‐operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non‐cardiac Surgery in Australia: A Trial‐Based Analysis · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Feasibility of Decentralised Response‐Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Metformin Ameliorates Diabetes‐Associated Cognitive Dysfunction via p53/Parkin‐Mediated Mitophagy · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Trends and Prevalence of Undiagnosed Dysglycemia Among Reproductive‐Age Women in the United States · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Beyond Glycaemia: Fear of Hypoglycaemia, Cognition and Functional Mobility After Advanced Hybrid Closed‐Loop Therapy in Older Adults With Type 1 Diabetes: A Prespecified Secondary Analysis of a Randomised, Single‐Centre Study · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Diagnostic Yield of Structured Cushing Syndrome Evaluation in Treatment‐Resistant Non‐Diabetic Obesity: A Retrospective Pilot Study · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Real‐World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study ( MEDFINE ‐ RWD ) · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Sodium Butyrate Attenuates Renal Fibrosis by Regulating Glycolysis and Histone H4K12 Lactylation in Diabetic Kidney Disease · Diabetes, Obesity and Metabolism · 2026 · Same journal